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Exposure to genotoxins may compromise DNA integrity in
male reproductive cells, putting future progeny at risk
for developmental defects and diseases. To study the
usefulness of sperm DNA damage as a biomarker for
genotoxic exposure, we have investigated cellular and
molecular changes induced by benzo[a]pyrene (B[a]P) in
human sperm in vitro, and results have been compared for
smokers and non-smokers. Sperm DNA obtained from ﬁve
smokers was indeed more fragmented than sperm of six
non-smokers (mean % Tail DNA 26.5 and 48.8, respec-
tively), as assessed by the alkaline comet assay (P < 0.05).
B[a]P-related DNA adducts were detected at increased
levels in smokers as determined by immunostaining. Direct
exposure of mature sperm cells to B[a]P (10 or 25 mM)
caused moderate increases in DNA fragmentation which
was independent of addition of human liver S9 mix for
enzymatic activation of B[a]P, suggesting some unknown
metabolism of B[a]P in ejaculates. In vitro exposure of
samples to various doses of B[a]P (with or without S9) did
not reveal any significant differences in sensitivity to DNA
fragmentation between smokers and non-smokers. Incuba-
tions with the proximate metabolite benzo[a]pyrene-
r-7,t-8-dihydrodiol-t9,10-epoxide (BPDE) produced DNA
fragmentation in a dose-dependent manner (20 or 50 mM),
but only when formamidopyrimidine DNA glycosylase
treatment was included in the comet assay. These levels of
DNA fragmentation were, however, low in relation to very
high amounts of BPDE–DNA adducts as measured with
32Ppostlabelling.WeconcludethatspermDNAdamagemay
be useful as a biomarker of direct exposure of sperm using
the comet assay adapted to sperm, and as such the method
maybeapplicabletocohortstudies.Although thesensitivity
is relatively low, DNA damage induced in earlier stages
of spermatogenesis may be detectedwith higherefﬁciencies.
Introduction
Environmental pollutants such as products of fossil fuel
combustion and contaminants in food and water are—together
with lifestyle factors—unquestionably linked to human health.
One such compound is the polycyclic aromatic hydrocarbon
(PAH), benzo[a]pyrene (B[a]P), an ubiquitous environmental
pollutant found in, e.g., cigarette smoke and grilled food. When
ingested or inhaled, B[a]P can be transformed by phase I
enzymes such as the CYP450 enzymes into several DNA-
reactive metabolites, including the directly acting carcinogen
benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE) [reviewed in
refs (1,2)], which binds covalently to DNA (3). BPDE can
also act in synergy with other exposures e.g. ultraviolet light
(4), ultimately increasing the risk of mutation, cancer or
possibly other adverse effects (5–7). B[a]P can also contribute
to the genotoxic burden in cells by reaction via the aldo-keto
reductase superfamily leading to oxidative stress [reviewed in
ref. (8)]. The oxidized quinones produced via this pathway may
in addition revert to catechols, which can react with DNA and
other biomolecules to form covalent adducts.
When mutations occur in male or female reproductive cells,
future progeny may be at risk of hereditary predispositions to
various developmental defects or disease including cancer.
Studies suggest that exposure to PAHs is correlated with
reduced semen quality and higher risk of infertility; men with
idiopathic infertility and also abnormal sperm parameters
[World Health Organization (WHO) criteria (1999)] were
shown to have increased levels of urinary PAH metabolites
compared to control groups (9). Moreover, studies have shown
that smoking men have higher levels of BPDE–DNA adducts
than non-smokers and that the level of adducts in embryos
from smoking couples seems to depend more on the smoking
habit of the father than that of the mother, implying that the
adducts in embryos could be more of paternal origin (10,11).
Sperm is a useful human biomaterial, being available from
volunteering individuals and from sperm banks; sperm has
a well-studied physiology and there are established methods for
their characterization (WHO). For tissues such as white blood
cells and mouth mucous cells, the application of the comet
assay (12) has been useful in biomonitoring studies (13). This
assay traditionally detects DNA strand breaks and alkali-labile
sites (e.g. baseless sites in DNA), is fast and sensitive and can
readily be modiﬁed to achieve higher speciﬁcity for the
detection of speciﬁc types of DNA lesions (14–18). Analysis of
human sperm using the comet assay [reviewed in (19) and
(20)] provides information on DNA integrity in relevance to
male fertility, and the method may supplement established
techniques e.g. sperm chromatin structure assay and terminal
deoxynucleotidyl transferase deoxyuridine triphosphate nick
end labelling (TUNEL) assay. In addition to issues relating to
fertility, DNA damage in the mature sperm may provide
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In vivo, such DNA lesions may arise in dividing testicular stem
cells or at varying stages during spermatogenesis and
spermiogenesis. The susceptibility at the various stages to
chemicals will depend on the ability of the cells to remove the
damage by DNA repair (21–26), but it also relates to the
packaging and restructuring of the chromatin at the various
stages, including replacement of histones with protamines
which occurs progressively during spermiogenesis [reviewed
in refs (27,28)]. Mature sperm could potentially have a great
potential as biomarker for genotoxic exposure in vivo when
assayed with the comet assay. This, however, requires that
induced lesions are measurable in a sensitive and robust
manner. If human sperm collected from healthy men is
susceptible to DNA damage induction after chemical treatment
in vitro, it is likely that mature sperm may also be damaged in
situ at a late stage of maturation, i.e. in the epididymis.
The present study was undertaken to evaluate the use of
sperm DNA damage as a biomarker in population studies. Using
B[a]P as an example of environmental exposure, semen samples
were exposed to this compound or its proximate metabolite
BPDE in vitro. Samples were obtained repetitively from one
donor or from groups of donors representing smokers and non-
smokers. The experiments were carried out in three laboratories,
using the comet assay adapted to sperm; in addition, DNA
adducts were analysed in some samples after exposure to B[a]P
or BPDE in vitro,u s i n g
32P postlabelling and immunostaining.
Materials and methods
Chemicals
Benzo[a]pyrene-r-7,t-8-dihydrodiol-t9,10-epoxide [( )anti-BPDE] was
obtained from the National Cancer Institute (NCI), Chemical Carcinogen
Reference Standard Repository at the Midwest Research Institute, Kansas City,
MO, USA (0477 NCI#: L0137# Batch: 42 Lot.: 01262007-PSU). B[a]P
(48564-SUPELCO) was obtained from Sigma-Aldrich, Munich, Germany.
SYBRGold was from Molecular Probes, Invitrogen, Paisley, UK; ethidium
bromide was from Sigma, Gillingham, Dorset, UK. Proteinase K was from
Hoffman-La Roche, Basel, Switzerland. Other chemicals were pro analysi
grade from commercial suppliers.
Human liver fraction S9-mix and essential reagents Pooled human liver S9-
mix (10 individuals, mixed gender) was obtained from In vitro Technologies,
Cat. no. X008023—LOT RTO. Glucose-6-phosphate (G-6-P), glucose-6-
phosphate dehydrogenase (G-6-P DH), grade I from yeast and nicotinamide
adenine dinucleotide phosphate (NADP) were obtained from Roche Diag-
nostics, Mannheim, Germany.
Semen samples
Semen samples were obtained from healthy volunteers after informed consent,
at the University of Bradford after 3–5 days of sexual abstinence. Detailed
information on age, ethnicity, sexual activity and children (and also other
factors e.g. occupation, smoking and drinking habits, vitamin intake, existing
urogenital pathologies, X-ray exposure, chemotherapy) was collected for other
purposes but was not used for further analysis because of the small sample size.
Smoking habits were conﬁrmed by cotinine levels measured in seminal plasma
(data not shown). The samples were labelled with date and time of collection
and given an anonymous donor code. Routine analysis of semen quality was
conducted within 2 h of collection using WHO criteria (1999) to provide details
on colour, volume, viscosity, sperm concentration, pH, motility and
morphology; all samples were found to be normospermic. All samples were
aliquoted, snap frozen in liquid nitrogen and then kept at  80C. Treated
samples (5, 10 and 25 lMB [ a]P   S9 mix or 5, 20 and 50 lM BPDE) from
three separate experiments were frozen and shipped to the participating
laboratories for
32P postlabelling analysis. Ethical approval was obtained from
the Research Ethics Sub-committee for Human Subjects at Bradford University
in June 2005.
Cell treatments
Aliquots of 2–5 ll from a thawed sperm sample were incubated for 1 h in 1
ml solutions of phosphate-buffered saline (PBS), pH 7.4, with either 1, 5, 10
or 25 lMo fB [ a]P dissolved in dimethyl sulfoxide (DMSO; end
concentration 1%),  1% human liver fraction S9-mix or 5, 20 and 50 lM
BPDE (DMSO 1%), at 32C. X irradiation was used as positive control and
was calibrated using Fricke’s ferrous sulphate chemical dosimetry. The
reduced nicotinamide adenine dinucleotide phosphate regenerating system
(NRS) and the S9-mix (S9 þ NRS) were freshly prepared before each
experiment as previously described (29). When mixing the ingredients, the
S9 fraction and the G-6-P DH were added at last to the mix, immediately
before addition to the cells for exposure (NRS end concentrations: 33 mM
potassium chloride (KCl), 8 mM magnesium chloride (MgCl2*6H2O), 5 mM
G-6-P, 3,75 U/ml G-6-P DH, 4 mM NADP, 0.3   PBS). For immunostaining
analysis, sperm aliquots were incubated as described above but with 40 lM
of B[a]P þ S9-mix or with vehicle alone.
Alkaline comet assay
Two different methods were applied to study comet formation in mature sperm
after incubation with B[a]P, and essential differences between protocols are
mentioned in Table I. The two protocols were initially established to obtain
relatively stable baseline levels of DNA damage of donor samples. They were
then used as part of a large European Commission (EC) project (NewGeneris)
to study various genotoxic and immunotoxic compounds using various end
points including human sperm.
Table I. Differences in comet assay Protocols 1 and 2
Experimental conditions Protocol 1 Protocol 2
Layers 1. Layer: normal slide with 1% NMP 1. Layer: GelBond ﬁlms using a 12-well format (4   3
wells)
2. Layer: 1:1 cells with 2.0% LMP (end
concentration 1%)
2. Layer: 1:10 cells with 1.7% LMP (end concentration
1.53%)
3. Layer: 0.5% LMP
Lysis 1. Lysis: slides in lysis buffer with 10 mM DTT, at 4C,
for 60 min
1. Lysis: gel bond ﬁlms in lysis buffer at 4C, over night
2. Lysis: slides in lysis stock with 0.05 mg/ml proteinase
K, at 4C, for 60 min
2. Lysis: gel bond ﬁlms in lysis buffer with 10 mM DTT,
at 4C, for 60 min
3. Lysis: gel bond ﬁlms in 100 mM Trizma buffer with
4 mM lithium diiodosalicyclate, pH 7.6, at ambient
temperature, for 90 min
Enzyme treatment 1 lg/ml FPG
DNA unwinding Electrophoresis buffer pH 13.2, 20 min Electrophoresis buffer pH 13.2, 20 min
Electrophoresis Electrophoresis: 25 V (0.78 V/cm) and not exceeding
300 mA at 4C for 20 min
Electrophoresis: 20 V (0.8 V/cm) and 300 mA at 8C for
20 min
After electrophoresis pH neutralization pH neutralization and ﬁxation in ethanol (.70%) for
90 min, dried and stored
Staining: ethidium bromide Staining: SYBRGold
LMP, low melting point agarose; NMP, normal melting point agarose.
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418Comet assay Protocol 1 This protocol is based on Singh et al. (30), with
modiﬁcations. Following exposure, sperm samples were centrifuged for 10 min
at 450 g at room temperature, resuspended in cold PBS and kept on ice until
mixed 1:1 with 2% low melting point agarose. The samples were cast onto
standard glass slides pre-coated with 1% normal melting point agarose. Cell
lysis was achieved through submerging the slides in two consecutive lysis
solutions: (i) lysis buffer (2.5 M NaCl, 100 mM Na2 ethylenediaminetetraacetic
acid (EDTA), 10 mM Trizma base, 1% Triton X-100, pH 10) containing 10
mM dithiothreitol (DTT) for 60 min at 4C and (ii) lysis buffer containing 0.05
mg/ml proteinase K for 60 min at 4C. After lysis, the slides were incubated in
electrophoresis buffer (300 mM NaOH, 1 mM Na2EDTA, pH 13.2) at 4C for
20 min to unwind DNA and then subjected to electrophoresis at 25 V (0.8 V/cm
on platform, 300 mA) for 20 min at 4C. Prior to staining with ethidium
bromide (20 lg/ml) for 10 min, the slides were neutralized (0.4 M Trizma
base, pH 7.5) three times for 5 min each. Comet visualization and scoring was
performed with a Leica ﬂuorescence microscope equipped with a Charge
Coupled Device (CCD) camera using the image analysis software ‘Komet 4’
from Kinetic Imaging Ltd.
Comet assay Protocol 2 The general comet assay protocol is also based on
Singh et al. (30) but was performed as adapted for sperm (31), with some
modiﬁcations: following exposure, sperm samples were centrifuged for 8 min
at 700 g at room temperature to avoid precipitation of B[a]P, resuspended in
1m lo fc o l dP B Sa n dk e p to ni c eu n t i lm i x e d1 : 1 0w i t h1 . 7 %l o wm e l t i n g
point agarose. Samples (60 ll) were cast onto 8   11 cm GelBond ﬁlms
using a 12-well format. Cell lysis was achieved through submerging the ﬁlms
in three consecutive lysis solutions: (i) lysis buffer: 2.5 M NaCl, 100 mM
Na2EDTA, 10 mM Trizma base, 1% Triton X-100, pH 10, at 4C,
overnight; (ii) lysis buffer with 10 mM DTT, pH 10, at 4C, for 60 min and
(iii) 100 mM Trizma buffer with 4 mM lithium diiodosalicylate, pH 7.6, at
ambient temperature, for 90 min. After lysis, all ﬁlms were equilibrated in
enzyme buffer (40 mM HEPES, 100 mM KCl, 0.5 mM Na2EDTA, pH 8) at
4C for 60 min, after which the ﬁlms were incubated in pre-warmed enzyme
buffer with 0.2 mg/ml bovine serum albumin at 37C for 60 min with or
without 1 lg/ml (sufﬁcient for saturating cleavage of oxidative lesions
induced in human lymphocytes by Ro 12-9786 þ visible light; data not
shown) formamidopyrimidine DNA glycosylase (FPG) crude extract (A.K.
Olsen, personal communication). Enzyme treatment was followed by
unwinding in electrophoresis buffer (300 mM NaOH, 1 mM Na2EDTA,
adjusted to pH 13.2 with HCl) at 4C for 20 min, and electrophoresis at 20 V
(0.8 V/cm on platform, 300 mA) at 8C for 20 min. After 3   5 minutes of
neutralization in 0.4 M Trizma base, pH 7.5, ﬁlms were rinsed in water and
ﬁxed in ethanol (.70%) for 90 min and dried. Gels were rehydrated and
s t a i n e di nT r i s - E D T Ab u f f e r( 1m MN a 2EDTA, 10 mM Trizma HCl, pH 8)
with SYBERGold (1:12 000 dilution) for 20 min. Comet visualization and
scoring were performed using the image analysis software ‘Comet assay IV’
from Perceptive Instruments Ltd, Haverhill, Suffolk, UK, and an Olympus
BX51 ﬂuorescence microscope (Japan), with an A312f camera (Basler Vision
Technologies, Ahrensburg, Germany).
Immunodetection of monoclonal antibodies
Semen aliquots were centrifuged for 10 min at 450 g, the supernatant was
carefully discarded and the pellet was dissolved in 300 ll PBS and again spun
at 450 g for 10 min. This step was repeated twice to wash the sperm pellet
thoroughly. The pellet was then resuspended in a 3:1 methanol–acetic acid
solution (ﬁxative); during continuous mixing on a vortex, the ﬁxative was
slowly dropped into the tube in 30 ll steps to avoid clumping of the sperm
followed by incubation for 30 min. The ﬁxed sperm were then applied in 50 ll
drops to glass slides and air-dried for 3 h. The sperm were decondensed by
incubating slides in ice-cold 10 mM DTT in a Coplin jar for 30 min, washing
twice in 2  saline-sodium citrate buffer for 10 min each and dehydration in an
ethanol series (70, 90 and 100%) for 3 min each. Finally, slides were air-dried.
The decondensed sperm were permeabilized with 0.5% Triton X-100 and then
analysed under a light microscope to check the density and possible over-
decondensation. With a hydrophobic PapPen, an area with an optimal density
and quality was then marked for hybridization (10,11).
Unspeciﬁc binding sites were ﬁrst blocked with 10% goat serum in PBS,
followed by application of 100 ll 1:50 5D11 monoclonal antibody (Amersham,
Piscataway, NJ, USA) in 1% goat serum. Clone 5D11 was reported to react
directly with BPDE–DNA adducts as well as with diol epoxide–DNA adducts
of different PAHs in a cross-reaction (32). The slides were incubated in a moist
chamber at 4C for 16 h to allow slow and thorough recognition of DNA
adducts by the antibody. After hybridization, the slides were washed three
times in PBS for 10 min each, followed by adding 100 ll of a solution
containing the secondary goat anti-mouse antibody conjugated with biotin
(DakoCytomation, Cambridge, UK). After incubation for 40 min at room
temperature in a humid chamber, the slides were washed again three times in
PBS for 10 min each, followed by application of 100 ll of a solution containing
Streptavidin conjugated to horseradish peroxidase (DakoCytomation) and
incubation at room temperature for 40 min in a moist chamber. Slides were
washed twice in PBS for 10 min and ﬁnally for 10 min in double distilled H2O.
The peroxidase reaction was developed with the 3.3#-diaminobenzidine
enhanced liquid system (Sigma-Aldrich). As a negative control, sperm from
smokers were treated with 10% goat serum instead of the primary antibody,
followed by application of the secondary antibodies and peroxidise reaction
system. All slides were coded by co-workers and scored blindly. For the
evaluation of staining intensity (STI), each sperm cell was scored as negative
(STI 0), weak (STI 1), moderate (STI 2) or strong (STI 3) for a total of
100 sperm per semen donor. A staining intensity score (e.g. the sum of the
products for the STI levels 0–3, with STI 0 5 1 points, STI 1 5 2 points,
STI 2 5 3 points, STI 3 5 4 points) was calculated for each successfully
hybridized sperm sample (10,11). Images (Figure 4) were obtained using a
100  Pan-NeoFluar objective and a CCD-camera.
32P postlabelling
Spermatozoa obtained from frozen ejaculates were lysed overnight at 55C
using a buffer containing 20 mM Tris–HCl, 20 mM EDTA, 200 mM NaCl,
80 mM DTT, 4% sodium dodecyl sulphate and 250 lg/ml proteinase K. DNA
from the lysed spermatozoa was isolated using the DNeasy Tissue Kit
(Qiagen Westburg bv., Leusden, The Netherlands) according to manufac-
turers’ instructions with minor modiﬁcations: after the lysis of the cells,
Buffer AL and 100% ethanol (EtOH) were added. This mixture was brought
onto DNeasy Spin Columns and centrifuged. Thereafter, Buffer AW1 was
added to the column and centrifuged and next, the column was washed with
Buffer AW2. After centrifuging the column, the DNA was eluted in distilled
water and stored at  20C until use. The
32P postlabelling assay was
subsequently performed as described (33). Brieﬂy, DNA was digested using
micrococcal endonuclease and spleen phosphodiesterase. Unadducted
nucleotides were dephosphorylated by Nuclease P1 treatment and the
modiﬁed nucleotides were subsequently radiolabelled (50 lCi per sample) by
incubation with T4 polynucleotide kinase and c-
32P-ATP. Radiolabelled
adduct nucleotide biphosphates were separated by chromatography on
polyethylenimine-cellulose sheets from Machery-Nagel (Du ¨ren, Germany).
In each experiment, three standards of BPDE-modiﬁed DNA with known
modiﬁcation levels (1 adduct per 10
7,1 0
8 and 10
9 nucleotides) were run in
parallel for quantiﬁcation purposes using phosphor-imaging technology
(Molecular Dynamics, Sunnyvale, CA, USA).
High-performance liquid chromatography analysis of metabolites after
exposure of mature sperm to B[a]P
Sperm sample aliquots of 250 ll were exposed under two different conditions,
either unwashed in the presence of seminal plasma or washed in PBS. Washed
samples were prepared by centrifugation at 9300 g for 5 min; the plasma
above the cell pellets was removed and the pellets were resuspended and mixed
thoroughly in 250 ll PBS and centrifuged another 5 min. The supernatant was
then removed and the cell pellets were resuspended in a new 250 ll PBS. A
volume of 250 ll ejaculate or washed sperm cells was exposed to 10 lMB [ a]P
dissolved in DMSO. All incubations were performed at 32C for 1 or 24 h.
After incubation, the samples were extracted three times with 1 ml ethyl
acetate, which was subsequently evaporated under a continuous nitrogen ﬂow.
The residues were redissolved in 100% methanol and analysed by reversed
phase high-performance liquid chromatography (HPLC); the samples were
injected onto a Supelco Hypersil 5 column (250   3 mm). Elution was
performed by using two mobile phases: Mobile phase A contained 100%
methanol and Mobile phase B contained 40% methanol and 60% (v/v) water. A
gradient elution programme, with a ﬂow rate of 0.5 ml/min, started with 30% A
and 70% B for 5 min, then gradually changed to 90% A in 25 min, held at 90%
for 5 min, then back to 30% A in 2 min and held at 30% A for 3 min before the
next injection. Detection was performed by a Perkin Elmer model LS 30
ﬂuorescence spectrometer with 257 and .350 nm as excitation and emission
wavelengths, respectively.
Statistics
The comet assay sample differences were determined by one-way analysis of
variance with a Dunnett’s or Tukey’s post-hoc test, using SPSS 17. For
immunostaining, all generated data were processed with Metlab software for
the median and standard error. SPSS 15.0 was used to measure asymmetry of
the probability distribution and skewness and to measure if the results were
peaked or ﬂat relative to a normal distribution and kurtosis. All the
immunostaining data were found to violate normality and therefore, non-
parametric Mann–Whitney was used to test for signiﬁcant differences. If not
speciﬁed, the level of signiﬁcance is P , 0.05.
DNA damage in human sperm
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Comet assay analysis of sperm from non-smoking volunteers
Comet assay experiments using Protocol 1 showed moderate
but consistent increases in DNA strand breaks in sperm from
three donors, exposed to 10 or 25 lMo fB [ a]P (P , 0.05;
Figure 1). These increases were found without addition of liver
S9-mix.
In the in vitro experiments analysed by the comet Protocol 2,
sperm aliquots from only one donor were used. Ejaculates were
divided into several 50 ll aliquots and frozen at  80C so that
cells from the same ejaculate could be used repeatedly. During
the 2-year course of the project, about 10 ejaculates from the
same person were collected and used. No major difference in
response to chemical treatment in vitro was observed between
ejaculates, suggesting minor intra-individual differences during
the project period.
Exposure to either B[a]P or B[a]P plus S9-mix showed no
statistically signiﬁcant increase in DNA strand breaks, and the
inclusion of FPG treatment did not lead to B[a]P-associated
DNA damage (Figure 2a). BPDE produced weakly increased
levels of DNA damage at 20 and 50 lM, as compared to the
control (Figure 2b). These increases were signiﬁcant only with
FPG treatment (P , 0.05). These exposures were also repeated
with samples from a second donor, giving highly similar results
(data not shown).
Comet assay analysis comparing sperm from non-smokers and
smokers
On the basis of the differences observed between the responses
with the two protocols, Protocol 1 was chosen to study sperm
from ﬁve smokers and six non-smokers. These groups showed
signiﬁcant differences in their baseline DNA damage levels
and also differences in the levels obtained in samples when
treated in vitro with DMSO plus S9 or S9 alone; samples from
the smokers had higher levels of DNA damage than non-
smokers (P , 0.001; P 5 0.003; P 5 0.023, respectively)
(Figure 3). When the samples were treated with B[a]P in vitro,
there were dose-dependent increases in DNA damage, in both
groups (except non-signiﬁcant differences of smoker’s baseline
levels versus treatment of the same samples with 1 lM
B[a]P   S9). However, a further increase with S9 was only
observed in non-smoker samples exposed to either 1 or 25 lM
B[a]P (P 5 0.03; P 5 0.04, respectively).
In situ immunodetection in sperm cells from smokers and non-
smokers using a B[a]P monoclonal antibody
Table II summarises staining intensity levels using the BPDE–
DNA antibody, with samples from three smokers and three
non-smokers. The data are derived from typical images shown
in Figure 4; baseline values are shown as well as responses to
40 lMB [ a]P activated with 1% S9-mix. The STI score was
signiﬁcantly increased in smokers as compared to non-
smokers.
BPDE adducts analysed with
32P postlabelling in sperm
exposed in vitro
Sperm samples were treated in vitro with 5, 10 or 25 lM
B[a]P   S9 mix or 5, 20 or 50 lM BPDE. DNA was extracted
and analysed with the
32P postlabelling technique. No B[a]P-
induced adducts were detected by
32P postlabelling in samples
exposed to either B[a]P or B[a]P plus S9-mix (data not shown).
However, BPDE exposure led to a dose-dependent increase in
adduct levels; these levels were extremely high and far beyond
what is considered to be physiologically relevant (Figure 5).
HPLC analysis of metabolites after exposure of mature sperm
to B[a]P
Mature sperm obtained from an ejaculate is not expected to be
able to transform B[a]P into reactive metabolites, but the
positive results in the comet assay with B[a]P in our study
prompted a metabolite analysis by HPLC. Three B[a]P-related
metabolites were indeed detectable after 24 h of incubation of
sperm with 10 lMB [ a]P (data not shown). These derivatives
could not be chemically identiﬁed since they had different
retention times as compared to several known metabolites
(including 7,8-diol and 9,10-diol B[a]P). The unidentiﬁed
B[a]P metabolites had retention times very close, but not
similar to several known quinones (including 1,6-; 3,6- and
6,12-B[a]P-dione). Although the measured metabolites could
not be identiﬁed, these results suggest that mature human
sperm—or the seminal ﬂuid—is capable of some form of
oxidative metabolism of B[a]P.
Discussion
B[a]P has been extensively tested for its adverse effects in
a large number of in vitro and in vivo studies and much of its
toxicity is well documented. In general, metabolic activation by
endogenous enzymes is required for B[a]P to be genotoxic; in
particular, the metabolite BPDE is known to interact with
biomolecules such as proteins and DNA (34), with new
reactive B[a]P metabolites still being discovered (35). In vivo,
some B[a]P activation products probably have sufﬁcient
stability to be transported from cells or organs possessing the
ability to metabolize B[a]P, to cells or tissues lacking such
activity (36). We recently detected adducts in sperm from mice
exposed to B[a]P in vivo, strongly suggesting that B[a]P
activation products had diffused from metabolically competent
surrounding tissues (37). In view of the current understanding
of the metabolism of B[a]P, it is expected that there would be
Fig. 1. DNA damage in sperm from three donors, exposed to 10 or 25 lM
B[a]P (without human S9-mix). Data were assessed by one-way analysis of
variance with a Dunnett’s post-hoc test. The dose response is presented as
mean % Tail DNA   1SE. Each treatment group was compared to the control
group (1% DMSO); *P , 0.05. Experiments were repeated several times for
each donor (unexposed controls, n 5 10, 10 or 25 lMB [ a]P, n 5 4). Comet
assay Protocol 1.
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as sperm, assumed to be deﬁcient in metabolizing activity
when incubated in vitro. However, Anderson et al. have shown
genotoxic activities in both lymphocytes as well as sperm, of
various compounds generally assumed to require enzymatic
activation to be genotoxic (38–43).
DNA damage levels were assessed in B[a]P-exposed
samples using the alkaline comet assay. Two protocols were
employed to validate sperm DNA damage detection in two
different laboratories using similar chemical exposure regi-
mens. Contrary to what was expected, we observed a moderate
but signiﬁcantly increased level of DNA damage induced by
B[a]P. This effect of B[a]P was observed when using Protocol
1, but not with Protocol 2. Protocol 2 was able to detect DNA
damage after treatment with BPDE combined with FPG
treatment and also X-ray-induced lesions (at the high doses
Fig. 2. (a) DNA damage in sperm from one donor exposed to 0, 5, 10 or 25 lMB [ a]P (in 1% DMSO)   human S9-mix. Comet analysis with or without FPG. Data
represent the mean % Tail DNA   1SE, of three to six individual experiments, and were assessed by one-way analysis of variance (ANOVA) with a Tukeys’s post-
hoc test. No signiﬁcant differences were observed for the various treatments (except for the positive control, X-rays 200 Gy; P , 0.05) compared to baseline and
vehicle control samples. (b) DNA damage in sperm exposed to 0, 5, 20 or 50 lM BPDE in 1% DMSO. Comet analysis with or without FPG. Data are represented as
mean % Tail DNA from four to six individual experiments   1SE. Assessed by one-way ANOVA with a Tukeys’s post-hoc test. Only exposure to 20 or 50 lM
BPDE combined with FPG treatment induced signiﬁcantly (*P , 0.05) higher DNA damage levels compared to control samples. Positive control: X-rays 200 Gy.
Comet assay Protocol 2.
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induction in sperm). It is not likely that the different results
with the two protocols are related to inter-individual differ-
ences, since the response with Protocol 1 was highly uniform
for the 11 donors examined. Furthermore, the Protocol 2
experiments included a second donor (data not shown)
showing a very similar response to the other donor, to the
various treatments (negative to B[a]P   S9). Russo et al.
(44)—using a protocol similar to Protocol 1 to analyse human
sperm—reported DNA damage in the absence of S9 (at very
high concentrations, 500 lM), and increased levels of cellular
oxidants were measured. It was suggested that peroxidases
present in sperm are important for the oxidative stress induced
by B[a]P. A possible factor of importance for the two protocols
is the presence of light during in vitro cell exposure. Platt et al.
(45)—using the Comet Assay—reported that several PAHs
(including B[a]P) were found to induce DNA damage in V79
lung ﬁbroblasts when co-exposed to visible light, apparently
without a need for metabolic activation. We observed no
signiﬁcant effect of co-exposure of B[a]P and visible light
(data not shown).
Using the
32P postlabelling assay, extremely high levels of
BPDE–DNA adducts were measured in BPDE-exposed sperm
samples (Figure 5). By means of in situ immunodetection using
a monoclonal BPDE–DNA antibody, adducts were readily
detected also in samples exposed to B[a]P plus S9. This
increased staining was not paralleled by
32P postlabelling (data
not shown), suggesting the existence of B[a]P-related mod-
iﬁcations that were recognized by the antibody but could not be
detected by
32P postlabelling. The higher immunostaining
in smokers versus non-smokers (Figure 4) is in correspondence
with the data from Zenzes et al. (10,11,46). Similarly, the
observed higher baseline levels of DNA damage in sperm
from smokers compared to non-smokers in the comet assay
is in correspondence with the ﬁndings of Fraga et al. (47)
(Figure 3).
Most bulky DNA adducts induced by B[a]P/BPDE are
stable, and they are not detected as DNA breaks in the comet
assay in the absence of DNA repair (48,49). In a cell-free
system, BPDE reacts with not only DNA forming stable
adducts (notably, BPDE–N2–Gua) but also unstable ones
including BPDE–N7–guanine, N6–adenine and N3–cytosine
Fig. 3. DNA damage in sperm from ﬁve smokers and six non-smokers. DNA damage levels are shown [baseline and in vitro exposure to 0, 1, 10 and 25 lMo f
B[a]P (in 1% DMSO)   human S9-mix]. Data represent the mean % Tail DNA   1SE, from three individual experiments repeated for all treatments and samples.
Sperm from the smokers had signiﬁcantly higher levels of DNA damage compared to non-smokers (baseline, S9, S9 þ DMSO). For both groups, in vitro exposure
to B[a]P gave a dose-dependent increase in DNA damage. Comet assay Protocol 1.
Table II. Mean values for staining intensity levels in sperm cells of non-smokers and smokers
STI score STI 0 STI 1 STI 2 STI 3
Non-smokers, vehicle only (n 5 3, mean   SE) 69.0   2.3 36.0   3.74 59.0   4.8 5.0   1.4 0.0   0
Smokers, vehicle only (n 5 3, mean   SE) 182.0   15.2 3.0   1.87 37.0   5.3 35.0   3.0 25.0   10.0
P-value 0.050 0.050 0.046 0.050 0.037
Non-smokers, B[a]P treated (n 5 3, mean   SE) 186.0   5.1 0.0   0 34.0   3.0 46.0   3.9 20.0   4.3
Smokers, B[a]P treated (n 5 3, mean   SE) 216.0   9.4 0.0   0 22.0   3.2 40.0   5.0 38.0   8.3
P-value 0.050 1.000 0.050 0.275 0.127
Staining intensity levels (STI   SE) and statistical differences (P-values) are shown for sperm samples treated for 1 h with 40 lMB [ a]P plus S9 mix, or vehicle
alone and analysed with a monoclonal antibody to detect DNA adducts.
V. Sipinen et al.
422Fig. 4. In situ immunodetection with a monoclonal BPDE–DNA antibody, in sperm from smokers and non-smokers treated with 40lMB [ a]P (in 1% DMSO) and
human S9-mix. (a) Smoker sperm cells, untreated; (b) non-smoker sperm cells, untreated; (c) smoker sperm cells, treated with 40 lMB [ a]P and human S9-mix; (d)
non-smoker sperm cells, treated with 40 lMB [ a]P and human S9-mix; (e) control for smoker sperm cells, no primary antibody applied and (f) control for non-
smoker sperm cells, no primary antibody applied.
Fig. 5.
32P postlabelling analysis of BPDE adducts in sperm cells. Results for control (DMSO 1%), BPDE standard and sperm cells exposed to 5 lM BPDE are
shown.
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423(50,51). Unstable lesions caused by chemicals in cells may lead
to the formation of ring-opened bases which may in turn be
substrates for glycosylases such as FPG (52,53), as has been
demonstrated for methyl methanesulfonate (54). The ultimate
level of lesions that are detectable in the comet assay will also
be largely affected by the tight packaging of DNA in sperm
cells—even after extensive lysis and unwinding, as demon-
strated with X-rays.
Taken together, our ﬁndings with the different end points
seem to mostly correspond with the occurrence and the nature
of the various types of lesions induced by BPDE (or B[a]P plus
S9). However, the observed effects of B[a]P alone on sperm
DNA in vitro using Protocol 1 require alternative explanations.
The formation of unstable adducts from B[a]P is known to
occur via a one-electron oxidation; however, both CYP
enzymes and aldo-keto reductase are needed also for this
pathway (34). An ‘untraditional’ form of activation of B[a]P
therefore seems to be taking place, either via extracellularly or
via mitochondria. Some metabolism of B[a]P, possibly by
mature sperm, was conﬁrmed by the observation of B[a]P-
related metabolites after an in vitro incubation of sperm with
B[a]P, and the retention times of these unknown derivatives
indicated that they behaved like B[a]P quinones. Quinones are
known to generate reactive oxidative species and they have
both spermicidal and spermostatic effects (55). Anderson et al.
(56) suggested—based on experiments using the comet
assay—that the DNA damage induced by oestrogens in human
sperm in vitro may be due to quinone formation. Rivrud (57)
described an increased mutagenic activity of B[a]P in the Ames
test when seminal ﬂuid was included, suggesting that enzymes
in the seminal ﬂuid might be responsible for B[a]P activation.
In our comet experiments, the seminal ﬂuid was present during
chemical exposures but it was diluted more than 100-fold.
Conclusions
The presence of DNA adducts in sperm after in vitro B[a]P
exposure, as demonstrated with
32P postlabelling or immunos-
taining, suggests that mature sperm is susceptible to B[a]P
adduct induction also when exposed to this compound in vivo.
Correspondingly, sperm could possibly be used as a biomarker
for exposure to environmental chemicals, both for the
individual and at the group level. Differences in biomarker
levels may then be attributed to environmental and/or lifestyle
factors, which could ultimately be related to fertility and the
genetic integrity of sperm.
Despite the very high sensitivity of
32P postlabelling and
immunostaining, these techniques are time consuming. The
comet assay is quick and low cost and has been made more
suitable for cohort studies through the EC FP6 NewGeneris
project (http://www.newgeneris.org/). The differing results
obtained using the two separate comet assay protocols
emphasize the need for a standardized experimental pro-
cedure when applied to sperm (19). The observation of
higher levels of baseline sperm DNA damage in smokers
versus non-smokers suggests that lesions induced during
spermatogenesis may be speciﬁcally measured using the
comet assay.
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